Knee Cartilage Repair: The Real Value of PRP and Regenerative Medicine

Introduction

Knee pain and limited mobility often stem from cartilage wear or injury. Traditional treatments mostly focus on pain relief or arthroscopic debridement, but cannot repair cartilage. In recent years, regenerative medicine therapies such as PRP (platelet-rich plasma) and stem cells have raised high hopes, often described in promotional materials as "miraculous cartilage repair therapies." However, real-world data and clinical guidelines are more cautious. This article, based on evidence-based medicine, analyzes the actual value of PRP and regenerative medicine in knee cartilage repair, helping you see through the hype and make informed choices.

PRP: Mechanisms, Evidence, and Suitable Candidates

PRP is concentrated platelet plasma obtained by centrifuging autologous blood, rich in growth factors, and theoretically capable of stimulating chondrocyte proliferation and matrix synthesis. Clinically, PRP injections are commonly used for mild to moderate knee osteoarthritis (Kellgren-Lawrence grade II-III) or cartilage defects (ICRS grade I-II).

Level of evidence: Multiple randomized controlled trials (RCTs) show that PRP is superior to placebo or hyaluronic acid injections in relieving pain and improving function, especially in younger, more active patients. However, note that existing studies have high heterogeneity, injection protocols (single or multiple doses, with or without activation) are not standardized, and evidence for long-term effects (beyond 2 years) is limited. The American Academy of Orthopaedic Surgeons (AAOS) guidelines list it as a "moderate recommendation," not a strong one.

Suitable candidates: Not suitable for those with severe joint space narrowing (bone-on-bone) or full-thickness cartilage defects with loose bodies. Contraindicated in patients with blood disorders, infections, or those using anticoagulants.

Key note: PRP is not a "universal repair"—its main role is to slow degeneration and reduce inflammation, not to truly regenerate hyaline cartilage. Patients should have realistic expectations and combine it with physical therapy and weight management to maximize benefits.

Stem Cells and Tissue Engineering: Future Trends and Real-World Bottlenecks

Mesenchymal stem cells (MSCs), due to their multilineage differentiation potential and immunomodulatory properties, are considered the core of regenerative medicine. Currently, clinical use mostly involves autologous bone marrow- or adipose-derived MSCs, delivered via intra-articular injection or combined with scaffold materials for implantation.

Current evidence: Early studies and small-sample trials suggest that MSCs can improve pain and function, with some imaging showing cartilage-like tissue filling in defect areas. However, the International Society for Cellular Therapy (ISCT) points out that large-scale, long-term RCTs are lacking, and there is no consensus on optimal cell dose, source, or delivery method. Additionally, stem cell therapy faces ethical, regulatory, and cost issues, and carries potential complications such as heterotopic ossification and tumor risk, requiring careful evaluation.

Tissue engineering (e.g., autologous chondrocyte implantation, ACI) is another direction, suitable for larger cartilage defects (>2 cm²), but requires two surgeries, a long rehabilitation period, and high costs.

Real-world bottlenecks: Regenerative medicine is still in the "bench-to-bedside" translational stage, and not all institutions claiming "stem cell therapy" have legal qualifications. Patients should be wary of exaggerated claims and choose legitimate medical facilities with clinical trials or ethical approvals.

How to Choose: Stepped Care and Individualized Decision-Making

Treatment for knee cartilage injury should follow a stepped approach: basic treatment (rehabilitation exercises, weight loss, medication) → minimally invasive injections (PRP, hyaluronic acid) → arthroscopic surgery (microfracture, cartilage transplantation) → joint replacement. Regenerative medicine therapies are typically positioned in early or mid-stages as a "bridge" to delay surgery.

Key clinical decision points: 1) Clarify the extent of injury (MRI or arthroscopy); 2) Assess age, activity needs, and comorbidities; 3) Fully discuss with your doctor the expected benefits, risks, and costs of each therapy. For example, a 45-year-old running enthusiast with grade II cartilage wear may be suitable for PRP combined with rehabilitation; while a 60-year-old with severe arthritis may be better suited for total knee replacement.

Furthermore, treatment is not a one-time fix; postoperative rehabilitation and lifestyle adjustments are equally crucial. International guidelines recommend muscle strengthening (quadriceps, hamstrings), low-impact aerobic exercise (swimming, cycling), and neuromuscular control training to improve joint stability.

International Perspective: Considerations for Seeking Care in the US and Canada

For patients seeking more advanced treatments or second opinions, cross-border healthcare becomes an option. The US leads in regenerative medicine research, but costs are high and regulations are strict (FDA has approved only a few cell therapy products). Japan and South Korea have more lenient regulatory frameworks, but quality varies.

When choosing international medical institutions, consider: 1) Whether the institution has international accreditation (e.g., JCI); 2) Physician qualifications and involvement in relevant research; 3) Transparency and evidence base of treatment plans; 4) Comprehensive management (including preoperative evaluation, surgery/injection, and rehabilitation guidance).

As a cross-border medical platform, MeiJiaKang offers overseas expert teleconsultation, coordination for US medical visits, and follow-up services, helping you connect with internationally standard medical institutions. We adhere to evidence-based medicine and do not exaggerate the effects of any therapy. If you are considering regenerative medicine treatment, you can first check approximate costs via cost estimation and contact us for personalized advice.

Recommendations for International Patients

Rational understanding: PRP and stem cells are "potentially effective" rather than "miraculous cures." Rely on scientific literature and clinical guidelines, and be wary of exaggerated claims.

Comprehensive evaluation: Undergo detailed imaging (e.g., 3T MRI) and functional scores (e.g., IKDC, KOOS) to clarify the injury.

Stepped care: Prioritize basic treatments and PRP; if ineffective, consider more advanced interventions. Do not blindly pursue "latest technologies."

Choose legitimate institutions: For domestic treatment, verify qualifications; for cross-border treatment, pay attention to local regulations and institutional endorsements.

Long-term management: Regardless of therapy, rehabilitation training and habit improvement are fundamental. Regular follow-ups combined with physical therapy are essential to maintain joint health.

Knee health is vital to quality of life, and decisions require caution. MeiJiaKang is committed to providing professional information and global resources to help you navigate treatment options and regain mobility.